SCHEMBL18933478

SCHEMBL18933478

COCCN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c(C#N)cnc2cc1OC1CCOC1

nearest known ligand 0.70

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 20/20 0.70
▸ ERBB2 P04626 17/20 0.70
▸ SRC P12931 1/20 0.57
▸ KDR P35968 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14854790 1.00 EGFR (0.70) EGFRERBB2SRCKDR
SCHEMBL18933572 0.95 EGFR (0.68) EGFRERBB2SRCKDR
SCHEMBL15222038 0.95 EGFR (0.68) EGFRERBB2SRCKDR
SCHEMBL18933553 0.95 EGFR (0.70) EGFRERBB2
SCHEMBL15222037 0.95 EGFR (0.70) EGFRERBB2
SCHEMBL14854924 0.93 EGFR (0.79) EGFRERBB2SRCKDR
SCHEMBL14854926 0.93 EGFR (0.79) EGFRERBB2SRCKDR
SCHEMBL14855197 0.93 EGFR (0.79) EGFRERBB2SRCKDR
SCHEMBL14855198 0.93 EGFR (0.79) EGFRERBB2SRCKDR
SCHEMBL15222047 0.93 EGFR (0.67) EGFRERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3222620-B1 CYANOQUINOLINE DERIVATIVES TIANJIN HEMAY ONCOLOGY PHARMACEUTICAL CO LTD (CN) 2019-11-20 — — EP disclosed
EP-3222620-A1 CYANOQUINOLINE DERIVATIVES TIANJIN HEMAY ONCOLOGY PHARMACEUTICAL CO., LTD. (CN) 2017-09-27 — — EP disclosed
EP-2581372-B1 CYANOQUINOLINE DERIVATIVES TIANJIN HEMAY ONCOLOGY PHARMACEUTICAL CO LTD (CN) 2017-06-07 — — EP disclosed
Send feedback